XT
TARS icon

XTX Topco’s Tarsus Pharmaceuticals TARS Stock Holding History

XTX Topco’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.99M Buy
95,130
+43,496
+84% +$2.78M 0.08% 299
2026
Q1 		$3.62M Buy
51,634
+33,224
+180% +$2.32M 0.06% 455
2025
Q4 		$1.51M Buy
18,410
+13,438
+270% +$1M 0.04% 743
2025
Q3 		$295K Sell
4,972
-640
-11% -$31.5K 0.02% 1511
2025
Q2 		$227K Buy
+5,612
New +$253K 0.01% 1624
2025
Q1 		– Sell
-11,375
Closed -$630K – 3090
2024
Q4 		$630K Buy
+11,375
New +$517K 0.05% 575
2022
Q4 		– Sell
-17,865
Closed -$306K – 1496
2022
Q3 		$306K Buy
+17,865
New +$284K 0.08% 486

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

XTX Topco's TARS Position: Q2 2026 in Review

XTX Topco increased its Tarsus Pharmaceuticals (TARS) stake by 84% in Q2 2026, buying an estimated $2.78M and bringing the position to 95,130 shares worth $5.99M. The position accounts for 0.08% of the portfolio, ranked #299.

XTX Topco first reported a position in TARS in Q3 2022 and has held it in 7 quarters since. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • XTX Topco held 95,130 shares of Tarsus Pharmaceuticals worth $5.99M as of Q2 2026.
  • XTX Topco bought 43,496 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $2.78M.
  • Tarsus Pharmaceuticals made up 0.08% of XTX Topco's portfolio in Q2 2026, its #299 holding.
  • XTX Topco first reported a position in Tarsus Pharmaceuticals in Q3 2022 and has held it in 7 quarters since.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.